October 13, 2022
DARPA is the Technocrat/Transhumanist dark arm of the military/biodefense
"vaccines" were initially considered for military use
against biowarfare, but Moderna was used to test the concept on the
entire global population. The results have been disastrous but
leaders refuse to stop the injections. The cozy relationship between
DARPA and Moderna needs to be blown wide open.
Humans as Bioreactors.
How DARPA and Moderna
pioneered the idea
behind mRNA vaccines...
A nucleic acid vaccine is a vaccine that uses gene delivery methods,
such as lipid nanoparticles or viral vectors, to deliver some
quantity of either DNA or RNA into a cell.
The cell's own machinery,
in the form of RNA polymerases and ribosomes, uses these nucleic
acids as instructions to synthesize proteins.
In the case of a
nucleic acid vaccine, the protein in question is usually one of the
structural proteins of a virus, with the aim of generating an
antibody response against that specific protein, but this isn't the
only type of product that nucleic acid transfection can produce.
Gene transfection into cells can, in fact, make those cells produce
any kind of protein, with the right instructions, including
monoclonal antibodies, designer receptors, anything imaginable.
In the case of the
COVID-19 vaccines, the media and the medical establishment tried
getting around this by arguing that since the vaccines did not
change the recipient's DNA, that meant that they weren't gene
The introduction of foreign nucleic acids into the body to
generate foreign proteins
is by definition, gene therapy, regardless of whether or not
the subject's own genes are changed by it.
DNA and RNA are genetic
material, and if the immune system catches a cell producing
non-human proteins, some
seriously bad things will happen to that cell.
Unlike a virus,
which only binds to specific host factors expressed by specific cell
lines and is endocytosed in those specific cells, cationic lipids,
like the LNPs used in mRNA vaccines, are capable of transfecting
basically any type of cell with instructions to make proteins.
were investigated for many years as a means of delivering
Alzheimer's drugs to the brain, because they readily
bypass the blood-brain barrier.
When the thing
being delivered is a toxin, like SARS-CoV-2 Spike, however, there
are serious consequences.
MDPI - A Case Report: Multifocal
Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA
Vaccination against COVID-19
The current report
presents the case of a 76-year-old man with Parkinson's disease (PD)
who died three weeks after receiving his third COVID-19 vaccination.
The patient was first vaccinated in May 2021 with the ChAdOx1
nCov-19 vector vaccine, followed by two doses of the BNT162b2 mRNA
vaccine in July and December 2021.
The family of the deceased
requested an autopsy due to ambiguous clinical signs before death.
PD was confirmed by post-mortem examinations. Furthermore, signs of
aspiration pneumonia and systemic arteriosclerosis were evident.
However, histopathological analyses of the brain uncovered
previously unsuspected findings, including acute vasculitis
(predominantly lymphocytic) as well as multifocal necrotizing
encephalitis of unknown etiology with pronounced inflammation
including glial and lymphocytic reaction.
In the heart, signs of
chronic cardiomyopathy as well as mild acute lympho-histiocytic
myocarditis and vasculitis were present. Although there was no
history of COVID-19 for this patient, immunohistochemistry for
SARS-CoV-2 antigens (spike and nucleocapsid proteins) was performed.
Surprisingly, only spike protein but no nucleocapsid protein could
be detected within the foci of inflammation in both the brain and
the heart, particularly in the endothelial cells of small blood
Since no nucleocapsid protein could be detected, the
presence of spike protein must be ascribed to vaccination rather
than to viral infection.
The findings corroborate previous reports
of encephalitis and myocarditis caused by gene-based COVID-19
There has been a
major push for the adoption of nucleic acid vaccine tech in prior
years, largely hidden from the public eye. In order to begin tracing
it out, one must simply perform date range searches for the years
prior to 2020, for nucleic acid vaccines.
The cheerleaders of this
technology immediately reveal themselves.
Nature - mRNA vaccines - a new era in vaccinology
represent a promising alternative to conventional vaccine approaches
because of their high potency, capacity for rapid development and
potential for low-cost manufacture and safe administration.
their application has until recently been restricted by the
instability and inefficient in vivo delivery of mRNA.
Recent technological advances have now largely overcome these
issues, and multiple mRNA vaccine platforms against infectious
diseases and several types of cancer have demonstrated encouraging
results in both animal models and humans.
This Review provides a
detailed overview of mRNA vaccines and considers future directions
and challenges in advancing this promising vaccine platform to
widespread therapeutic use.
Frontiers - Advances in mRNA Vaccines
for Infectious Diseases
During the last two
decades, there has been broad interest in RNA-based technologies for
the development of prophylactic and therapeutic vaccines.
Preclinical and clinical trials have shown that mRNA vaccines
provide a safe and long-lasting immune response in animal models and
In this review, we summarize current research progress on
mRNA vaccines, which have the potential to be quick-manufactured and
to become powerful tools against infectious disease and we highlight
the bright future of their design and applications.
International Journal of Nanomedicine
- Development of nucleic acid vaccines: use of self-amplifying RNA
in lipid nanoparticles
or RNA replicon is a form of nucleic acid-based vaccine derived from
either positive-strand or negative-strand RNA viruses.
sequences encoding structural proteins in these RNA viruses are
replaced by mRNA encoding antigens of interest as well as by RNA
polymerase for replication and transcription.
This kind of vaccine
has been successfully assayed with many different antigens as
vaccines candidates, and has been shown to be potent in several
animal species, including mice, nonhuman primates, and humans.
challenge to realizing the broad potential of self-amplifying
vaccines is the need for safe and effective delivery methods.
Ideally, an RNA nanocarrier should provide protection from blood
nucleases and extended blood circulation, which ultimately would
increase the possibility of reaching the target tissue.
system must then be internalized by the target cell and, upon
receptor-mediated endocytosis, must be able to escape from the
endosomal compartment into the cell cytoplasm, where the RNA
machinery is located, while avoiding degradation by lysosomal
Further, delivery systems for systemic administration ought
to be well tolerated upon administration.
They should be safe,
enabling the multiadministration treatment modalities required for
improved clinical outcomes and, from a developmental point of view,
production of large batches with reproducible specifications is also
In this review, the concept of self-amplifying RNA
vaccines and the most promising lipid-based delivery systems are
Nature Gene Therapy - The promise of
nucleic acid vaccines
effective use of 'naked' nucleic acids as vaccines would undoubtedly
be one of the most important advances in the history of vaccinology.
While nucleic acids show much promise for use as vaccine vectors in
experimental animals, not a single naked nucleic acid vector has
been approved for use in humans.
Indeed, data from human clinical
trials is scant: nucleic acid vaccines have not been clearly
demonstrated to have any convincing efficacy in the prevention or
treatment of infectious disease or cancer.
Here we illustrate
possible mechanisms underlying effective nucleic acid vaccination.
We focus on progress that has been made in the improvement of their
Additionally, we identify promising new strategies and try
to forecast future developments that could lead to the real success
of nucleic acid vaccines in the prevention and treatment of human
Cell Press Molecular Therapy - Self-Amplifying RNA Vaccines Give Equivalent Protection against
Influenza to mRNA Vaccines but at Much Lower Doses
platforms are needed to address the time gap between pathogen
emergence and vaccine licensure.
RNA-based vaccines are an
attractive candidate for this role: they are safe, are produced cell
free, and can be rapidly generated in response to pathogen
Two RNA vaccine platforms are available: synthetic mRNA
molecules encoding only the antigen of interest and self-amplifying
RNA (sa-RNA). sa-RNA is virally derived and encodes both the antigen
of interest and proteins enabling RNA vaccine replication.
platforms have been shown to induce an immune response, but it is
not clear which approach is optimal. In the current studies, we
compared synthetic mRNA and sa-RNA expressing influenza virus
Both platforms were protective, but equivalent levels
of protection were achieved using 1.25 μg sa-RNA compared to 80 μg
mRNA (64-fold less material).
Having determined that sa-RNA was more
effective than mRNA, we tested hemagglutinin from three strains of
influenza H1N1, H3N2 (X31), and B (Massachusetts) as sa-RNA
vaccines, and all protected against challenge infection.
was combined in a trivalent formulation, it protected against
sequential H1N1 and H3N2 challenges.
From this we conclude that sa-RNA
is a promising platform for vaccines against viral diseases.
Again and again,
the same properties are touted; easy, rapid, cost-effective
development and manufacture. Plug in a gene sequence for the
targeted antigen and away you go.
military would be interested in this technology for quickly
vaccinating large populations of people against bioweapons ahead of
pandemic spread, because it offers the potential for rapid
development and deployment of countermeasures in a wartime scenario
with equally rapid-developed bioweapons being flung all over the
ADEPT is a
program that began in 2012.
The acronym stands for
Diagnostics to Enable Prevention and Therapeutics.
PROTECT is a
sub-program of ADEPT, and it stands for,
Environmental and Contagious Threats.
Some quick searches
reveal presentation slides about the project:
Autonomous Diagnostics to Enable
Prevention and Treatment (ADEPT)
diagnostics, vaccines, and therapeutics brought to the warfighter.
Cellular Machinery - Vaccines Antigens, immunomodulating elements,
and pharmacokinetics encoded in RNA vaccines
prophylactic protection against disease by treating people with
nucleic acid constructs that encode protective monoclonal
ADEPT Vignette Final
DARPA pioneered the
use of the body as a bioreactor to produce prophylactic antibodies
to protect against biothreats
goal of 'ADEPT: PROTECT' was to come up with nucleic acid delivery
systems that encoded monoclonal antibodies (or mAbs) against
specific pathogens that may be used in biowarfare, such as,
Influenza, Smallpox, SARS, Chikungunya, Rabies, Anthrax bacteria,
and even Ricin, nerve agents, and prions...
Antibodies are the
means by which the adaptive immune system tags things for
destruction and disposal.
They lock over the surface proteins of
pathogens and guide inactivated viruses and bacteria into
leukocytes, encourage complement activation, and so on.
antibodies are essentially copies of one specific kind of antibody,
for therapeutic use.
This differs slightly from how mRNA vaccines
have ended up being used; generating the target antigen protein
instead, and letting the body manufacture antibodies against it.
In DARPA's own
words, they partnered with Moderna to produce mRNA-1944, a nucleic
acid-encoded mAb against chikungunya:
In fact, DARPA
openly brag on Twitter that Moderna's mRNA vaccine tech - and, by
extension, mRNA-1273, was a product of ADEPT:
What's really going
Why haven't the media extensively covered the military
think tank side of all of this, as well as DARPA's enduring
partnership with Moderna?
Moderna failed to disclose federal
funding for vaccine patent applications, advocates say
An advocacy group
has asked the Department of Defense to investigate what it called
"an apparent failure" by Moderna (MRNA)
to disclose millions of dollars in awards received from the Defense
Advanced Research Projects Agency in patent applications the company
filed for vaccines.
letter to the agency, Knowledge Ecology International explained
of dozens of patent applications found the company received
approximately $20 million from the federal government in grants
several years ago and the funds "likely" led to the creation of its
This was used to develop vaccines to combat
different viruses, such as Zika and, later, the virus that causes
In arguing for an
investigation, the advocacy group maintained Moderna is obligated
under federal law to disclose the grants that led to nearly a dozen
specific patent applications and explained the financial support
means the U.S. government would have certain rights over the
In other words, U.S. taxpayers would have an ownership
stake in vaccines developed by the company.
There is an
extensive paper trail, here, one that shows that Moderna is just
another front in the Biodefense Mafia.
The media, with few
exceptions, are largely silent on this matter....
If we are at war - and at this point, only an idiot would fail to see that we are
- then who fired the first shot? Why are world leaders so tight-lipped
about all of this?
Well, it's simple, really.
The reason why you
have been kept in the dark is because you are the target of
a globe-spanning military operation, with population reduction, mass
surveillance, tyrannical control of people's movements, and the
destruction of human autonomy through implanted technology as its
In all of the
affluent nations operating under the globalist managerial
rules-based order of private-public partnerships, NGOs, and
supranational organizations, the only real threats to the ruling
class are resurgent nationalism, populism, and traditionalism,
because these things invariably lead to protectionist economic
policies that divert resources away from the already magnificently
wealthy ruling class and towards the middle.
Populism is only a
problem for the rich and powerful if there are people to embody it.
No people, no problem.
Hence the reliance on
The Neo-Malthusian ruling class want to kill off
insolent, rebellious, resource-overconsuming plebeians, keep the
valuable infrastructure intact, and profit off of it, after they
corral just enough survivors to keep their global consumerist orgy
They aren't even
discreet about it.
They openly revel in their extraordinarily
These people want
to control you, and if they can't control you, then they want to
replace you with someone they can.
The word for this condition is
a mania (see
MANIA sense 2a) for great or grandiose
performance an outburst of
wildly extravagant commercial megalomania The Times
Literary Supplement (London)
mental illness that is marked by feelings of personal
adjective or noun
adjective or less
We must throw all
of our energy into exposing these people and dismantling their
As they have clearly violated the social
contract and are scrambling desperately to conceal that fact, there
is no point whatsoever in obeying them. Their authority is now
We have every right
to defend ourselves and our kin from murderous despots who plot
against us in the dark.